NIH Common Fund Data Ecosystem: LINCS (CFDE-LINCS) FAIR Rubric

A rubric for evaluating the FAIRness of LINCS Resource

Tags: nihcommonfund


View Assessments

Associated Metrics (18)

Contact information is provided for the creator(s) of the dataset.


test fairshake

Globally unique identifier


Provide an URL to a registered scheme that defines the globally-unique structure of the identifier(s...

Machine-readable metadata


Provide the URL to a document that contains machine-readable metadata for the digital resource.

Standardized metadata


The URI of a registered metadata format in FAIRSharing (for example,

Resource identifier in metadata


The identifier that should explicitly appear in the metadata.

Open, Free, Standardized Access protocol


Provide a URL to the access protocol.

Digital resource license


Provide a URL to the license that governs the use of the digital resource.

Metadata license


Provide a URL to the license that governs the use of the digital resource.

The institution that created this dataset is available



A biological assay is present and resolvable in CFDE-specified ontology (OBI)


Previously BAO

nihcommonfund biology

A relevant anatomical part is present and resolvable in the UBERON Ontology


nihcommonfund biology

Associated Digital Objects (32)

LINCS L1000 Chemical Perturbations (2021)

LINCS L1000 Ligand Perturbations (2021)

LINCS L1000 Antibody Perturbations (2021)

LINCS L1000 siRNA Perturbations (2021)

LINCS L1000 CRISPR Perturbations (2021)

LINCS L1000 Overexpression Perturbations (2021)

LINCS L1000 shRNA Perturbations (2021)

LINCS chemical perturbagen signatures

Transcriptional signatures of perturbations by small molecules based on L1000 assay. The signature c...

LINCS consensus gene (CGS) knockdown signatures

Transcriptional signatures were constructed by further aggregating signatures of individual shRNA pe...

Broad Institute L1000 Connectivity Map and RNAseq gene expression profiles on tissue samples from the GTEx project

L1000 Dataset -small molecule, CRISPR perturbagens- LINCS Phase 2 (December 2015)